Tag: Mabion

Mabion Returns to CD20 Project After Signing Letter of Intent with France’s Oddifact

Mabion S.A., a Polish biotechnology company, has signed a letter of intent with French firm Oddifact SAS for the joint development of MabionCD20. The...

Mabion Announces Updated 2025–2030 Strategy

Mabion has unveiled its updated development strategy aimed at strengthening the Company’s position as a flexible, technologically advanced CDMO, securing new service-model contracts, and...
HomeTagsMabion